FBIO Fortress Biotech Inc
8,021
$1.93
$0.17
(9.66%)
| Watchers | 8,021 |
| 52-Wk Low | $1.24 |
| 52-Wk High | $10.65 |
| Market Cap | $37.12M |
| Volume | 334,417.00 |
| 52-Wk High | $10.65 |
| 52-Wk Low | $1.24 |
FBIO Stock Earnings: Fortress Biotech Beats EPS, Beats Revenue for Q4 2023InvestorPlace • about 2 months ago
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
FBIO stock results show that Fortress Biotech beat analyst estimates for earnings per share and beat on revenue for the fourth quarter...
Share to Feed
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Record consolidated net revenue of $84.5 million for full-year 2023 Fortress may receive up to four regulatory decisions on NDAs and BLAs in the next 18 months FDA accepted New Drug Application...
Planning for proof-of concept Phase 1 investigator-sponsored clinical trial evaluating MB-106 CD20-targeted CAR T-cell therapy in autoimmune diseases is underway and expected to initiate in the...
MIAMI, March 25, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) ( Avenue or the Company ), a specialty pharmaceutical company focused on the development and commercialization...
WALTHAM, Mass., March 22, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. ( Checkpoint ) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced...
Company generated total revenues of $79.2 million for the full year ended December 31, 2023, a 7% increase from the $73.7 million reported in 2022 Achieved $15.6 million in operating cost...
Research analysts at Alliance Global Partners assumed coverage on shares of Fortress Biotech (NASDAQ:FBIO Get Free Report) in a note issued to investors on Tuesday, Benzinga reports. The firm...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Fortress Biotech, Inc. (NASDAQ:FBIO Get Free Report) was the recipient of a large decline in short interest in February. As of February 29th, there was short interest totalling 1,540,000...